para-Methoxyamphetamine

PMA
Clinical data
Other namespara-Methoxyamphetamine; p-Methoxyamphetamine; PMA; 4-Methoxyamphetamine; 4-MA; 4-MeO-A; 4-OMe-PIA
Routes of
administration
Oral
Drug classSerotonin releasing agent; Serotonin receptor modulator; Serotonergic psychedelic; Hallucinogen; Monoamine oxidase inhibitor
ATC code
  • None
Legal status
Legal status
Pharmacokinetic data
Duration of action"Short"
Identifiers
  • 1-(4-methoxyphenyl)propan-2-amine
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.525
Chemical and physical data
FormulaC10H15NO
Molar mass165.236 g·mol−1
3D model (JSmol)
  • C1=CC(=CC=C1CC(C)N)OC
  • InChI=1S/C10H15NO/c1-8(11)7-9-3-5-10(12-2)6-4-9/h3-6,8H,7,11H2,1-2H3 checkY
  • Key:NEGYEDYHPHMHGK-UHFFFAOYSA-N checkY
 X markNcheckY (what is this?)  (verify)

para-Methoxyamphetamine (PMA), also known as 4-methoxyamphetamine (4-MA), is a designer drug of the amphetamine class with serotonergic effects. Unlike other similar drugs of this family, PMA does not produce stimulant, euphoriant, or entactogenic effects, and behaves more like an antidepressant in comparison, though it does have some psychedelic properties.

PMA has been found in black market tablets sold as MDMA (ecstasy) although its effects are markedly different compared to those of MDMA. The consequences of such deception have often included hospitalization and death for unwitting users. PMA is commonly synthesized from anethole, the essential oil of anise and fennel, mainly because the starting material for MDMA and MDA, safrole (a major component of the essential oil of sassafras), has become less available due to increasing government controls, causing illicit drug manufacturers to make PMA as an alternative.